[breadcrumb_custom]

Tenaya Therapeutics Inc (TNYA) Stock: A Year of Decreases and Increases

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Tenaya Therapeutics Inc’s current trading price is -39.43% away from its 52-week high, while its distance from the 52-week low is 195.24%. The stock’s price range during this period has varied between $1.66 and $8.09. The company, active in the Healthcare sector, saw a trading volume of around 1.05 million for the day, considerably higher average daily volume of 0.43 million observed over the last three months.

In terms of market performance, Tenaya Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $8.09 on 06/06/23, while the lowest value was $1.66 on 10/27/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

How Financial Performance Impacts Market Capitalization

Tenaya Therapeutics Inc (TNYA) has experienced a quarterly rise of 139.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 333.81M and boasts a workforce of 141 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.67, with a change in price of +1.90. Similarly, Tenaya Therapeutics Inc recorded 434,185 in trading volume during the last 100 days, posting a change of +59.19%.

How TNYA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TNYA stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.05.

TNYA Stock Stochastic Average

As of today, the raw stochastic average of Tenaya Therapeutics Inc over the last 50 days is at 83.97%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 79.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 69.06% and 64.29%, respectively.

TNYA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 51.27%. However, over the last six months, the performance has been weaker by 17.25%. The price of TNYA increased 57.08% over the last 30 days. And in the last five days, it has surged by 3.18%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts